Type I n (%) 47 (13.0) | Type IIa n (%) 128 (35.5) | Type IIb n (%) 109 (30.2) | Type IIc n (%) 35 (9.6) | Type IIIa n (%) 14 (3.9) | Type IIIb n (%) 14 (3.9) | Type IV n (%) 14 (3.9) | p | |
---|---|---|---|---|---|---|---|---|
Age, median | 74 | 70 | 72 | 74 | 79 | 80 | 75 | 0.074 |
Sex, n (%) | 0.528 | |||||||
Male | 24 (51) | 55 (43) | 49 (45) | 15 (43) | 4 (29) | 3 (21) | 6 (43) | |
Female | 23 (49) | 73 (57) | 60 (55) | 20 (57) | 10 (71) | 11 (79) | 8 (57) | |
Final diagnosis, n (%) | ||||||||
CBD stones | 23 (48.9) | 83 (64.9) | 51 (46.8) | 20 (57.1) | 11 (78.6) | 7 (50.0) | 3 (21.4) | 0.010 |
Malignant stricture | 16 (34.0) | 22 (17.2) | 26 (23.9) | 7 (20) | 1 (7.1) | 1 (7.1) | 5 (35.7) | 0.229 |
Leaks | 1 (2.1) | 3 (2.3) | 5 (4.6) | 1 (2.9) | 0 | 0 | 0 | 0.935 |
Other findings | 7 (15.0) | 20 (15.6) | 27 (24.8) | 7 (20.0) | 2 (14.3) | 6 (42.9) | 6 (42.9) | 0.356 |